Eptifibatide PHARMALOGY, production equipment,Side effects,powder,News,Services, exporters, manufacturers, suppliers, wholesale, Traders, factories, Companies

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Eptifibatide Taj Pharmaceuticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Eptifibatide Manufacturers in India Suppliers Eptifibatide Exporters Distributors Eptifibatide api active pharmaceuticals ingredients Eptifibatide manufacturers Side Effects bulk drugs raw material Eptifibatide companies Side Effects Importers Eptifibatide Eptifibatide Exporters Eptifibatide exporters FDA Eptifibatide DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Eptifibatide manufacturing pharmaceutical drugs pharmaceutical intermediates Eptifibatide pharmaceutical chemicals pharmaceutical raw materials Eptifibatide active pharmaceutical ingredients Eptifibatide committee active pharmaceutical ingredients manufacturer Eptifibatide Active Pharmaceutical Ingredients manufacturer Eptifibatide exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Eptifibatide, Eptifibatide manufacturer India, Eptifibatide product, Eptifibatide products, Api preparation, Certificate of Analysis API manufacturer product, Eptifibatide anti ulcer product, Certificate of Origin COA Eptifibatide COS Eptifibatide, pharmaceutical generic, pharmaceutical drug, medical, Eptifibatide pharma healthcare, pharma patents, contract MSDS manufacturing Trader Eptifibatide pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Eptifibatide expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Eptifibatide DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Eptifibatide ingredients, api, HIV Eptifibatide, tablets, capsules, syrup & protein Eptifibatide powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Eptifibatide gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Eptifibatide WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Eptifibatide Chemical-data

HOME >> API >> API List1 >> Eptifibatide >> Pharmalogy

PHARMALOGY
Eptifibatide CAS no.: 188627-80-7

Mechanism of Action

Eptifibatide reversibly inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands to GP IIb/IIIa. When administered intravenously, eptifibatide inhibits ex vivo platelet aggregation in a dose- and concentration-dependent manner. Platelet aggregation inhibition is reversible following cessation of the eptifibatide infusion; this is thought to result from dissociation of eptifibatide from the platelet.
Patients in clinical studies were older (range 20-94 years) than those in the clinical pharmacology studies. Elderly patients with coronary artery disease demonstrated higher plasma levels and lower total body clearance of eptifibatide when given the same dose as younger patients. Limited data are available on lighter weight ( < 50 kg) patients over 75 years of age.Eptifibatide was studied in three placebo-controlled, randomized studies. PURSUIT evaluated patients with acute coronary syndromes: unstable angina (UA) or non-ST-segment elevation MI (NSTEMI). Two other studies, ESPRIT and IMPACT II, evaluated patients about to undergo a percutaneous coronary intervention (PCI). Patients underwent primarily balloon angioplasty in IMPACT II and intracoronary stent placement, with or without angioplasty, in ESPRIT.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

PHARMALOGY >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.